{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study+Powder&page=4", "query": { "intervention": "Study Powder", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 1207, "total_pages": 121, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study+Powder&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study+Powder&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-30T13:24:38.939Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03291951", "title": "FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Resistance Training", "Colon Cancer", "Chemotherapy Effect" ], "interventions": [ { "name": "Resistance training", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Kaiser Permanente", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 183, "start_date": "2018-02-23", "completion_date": "2022-03-21", "has_results": false, "last_update_posted_date": "2022-07-28", "last_synced_at": "2026-10-30T13:24:38.939Z", "location_count": 3, "location_summary": "Oakland, California • Boston, Massachusetts • Hershey, Pennsylvania", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Hershey", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03291951" }, { "nct_id": "NCT01637272", "title": "Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dumping Syndrome" ], "interventions": [ { "name": "SOM230", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 43, "start_date": "2013-01-08", "completion_date": "2015-08-07", "has_results": true, "last_update_posted_date": "2017-05-10", "last_synced_at": "2026-10-30T13:24:38.939Z", "location_count": 6, "location_summary": "La Jolla, California • Stanford, California • Rochester, Minnesota + 3 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "The Bronx", "state": "New York" }, { "city": "El Paso", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01637272" }, { "nct_id": "NCT01134042", "title": "Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Furoate/Vilanterol Inhalation Powder", "type": "DRUG" }, { "name": "Fluticasone Furoate Inhalation Powder", "type": "DRUG" }, { "name": "Fluticasone Propionate Inhalation Powder", "type": "DRUG" }, { "name": "Placebo Inhalation Powder 1", "type": "OTHER" }, { "name": "Placebo Inhalation Powder 2", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 587, "start_date": "2010-06", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2017-01-11", "last_synced_at": "2026-10-30T13:24:38.939Z", "location_count": 23, "location_summary": "Bell Gardens, California • Huntington Beach, California • Long Beach, California + 19 more", "locations": [ { "city": "Bell Gardens", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01134042" }, { "nct_id": "NCT04466761", "title": "Ascending Glycan Dietary Supplementation in Healthy Adults", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Individuals" ], "interventions": [ { "name": "Monosaccharide Powder", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo Comparator", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "University of California, Davis", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 14, "start_date": "2022-06-23", "completion_date": "2024-08-06", "has_results": false, "last_update_posted_date": "2024-11-12", "last_synced_at": "2026-10-30T13:24:38.939Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04466761" }, { "nct_id": "NCT03137992", "title": "Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Test Product (tiotropium bromide inhalation powder)", "type": "DRUG" }, { "name": "Reference Product (Spiriva®)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lupin, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 377, "start_date": "2017-11-21", "completion_date": "2018-04-30", "has_results": true, "last_update_posted_date": "2021-04-05", "last_synced_at": "2026-10-30T13:24:38.939Z", "location_count": 34, "location_summary": "Andalusia, Alabama • Jasper, Alabama • Glendale, Arizona + 28 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03137992" }, { "nct_id": "NCT01825616", "title": "Vitamin D2, Muscle Damage, NASCAR Pitcrew", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Muscle Function", "Muscle Soreness", "Vitamin D Status" ], "interventions": [ { "name": "Vitamin D2 mushroom powder", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Appalachian State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "40 Years", "sex": "MALE", "summary": "20 Years to 40 Years · Male only" }, "enrollment_count": 33, "start_date": "2012-10", "completion_date": "2013-01", "has_results": false, "last_update_posted_date": "2013-04-09", "last_synced_at": "2026-10-30T13:24:38.939Z", "location_count": 3, "location_summary": "Kannapolis, North Carolina", "locations": [ { "city": "Kannapolis", "state": "North Carolina" }, { "city": "Kannapolis", "state": "North Carolina" }, { "city": "Kannapolis", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01825616" }, { "nct_id": "NCT00980200", "title": "Efficacy and Safety Study in Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Dose 4 QD", "type": "DRUG" }, { "name": "Dose 3 QD", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "Dose 2 QD", "type": "DRUG" }, { "name": "Dose 1 BD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 75, "start_date": "2009-09", "completion_date": "2010-01", "has_results": true, "last_update_posted_date": "2017-01-30", "last_synced_at": "2026-10-30T13:24:38.939Z", "location_count": 9, "location_summary": "Cypress, California • Huntington Beach, California • Bethesda, Maryland + 6 more", "locations": [ { "city": "Cypress", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Rolla", "state": "Missouri" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00980200" }, { "nct_id": "NCT05303207", "title": "Study to Evaluate the Efficacy of YOUR SUPER Detox Bundle to Improve Perceived Well Being and Promote Adaptation of Healthy Dietary Choices", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Eating Habit", "Healthy Diet" ], "interventions": [ { "name": "YOUR SUPER Detox Bundle", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Your Super, INC.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 38, "start_date": "2022-03-15", "completion_date": "2022-04-30", "has_results": false, "last_update_posted_date": "2022-06-14", "last_synced_at": "2026-10-30T13:24:38.939Z", "location_count": 1, "location_summary": "Santa Monica, California", "locations": [ { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05303207" }, { "nct_id": "NCT03886311", "title": "Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sarcoma" ], "interventions": [ { "name": "Talimogene Laherparepvec 100000000 PFU/1 ML Injection Suspension [IMLYGIC]", "type": "DRUG" }, { "name": "Nivolumab IV Soln 100 MG/10ML", "type": "DRUG" }, { "name": "Trabectedin 0.25 MG/1 VIAL Intravenous Powder for Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sarcoma Oncology Research Center, LLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2019-05-15", "completion_date": "2031-07-31", "has_results": false, "last_update_posted_date": "2025-02-24", "last_synced_at": "2026-10-30T13:24:38.939Z", "location_count": 1, "location_summary": "Santa Monica, California", "locations": [ { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03886311" }, { "nct_id": "NCT00870584", "title": "Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Persistent Allergic Asthma" ], "interventions": [ { "name": "Omalizumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 271, "start_date": "2009-03", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2011-11-17", "last_synced_at": "2026-10-30T13:24:38.939Z", "location_count": 50, "location_summary": "Jasper, Alabama • Anchorage, Alaska • Scottsdale, Arizona + 46 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00870584" } ] }